Chemical Compound

1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione Mixt. Contg.; 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)pyrimidinetrione Mixt. Contg. (9CI); Atrium; Atrium (pharmaceutical); 1,3-Bis[2-[(aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-Pyrimidinetrione Mixt. with 1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;

CAS Registry Number 60763-47-5
1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione Mixt. Contg.; 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)pyrimidinetrione Mixt. Contg. (9CI); Atrium; Atrium (pharmaceutical); 1,3-Bis[2-[(aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-Pyrimidinetrione Mixt. with 1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 结构式
Primary record

1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione Mixt. Contg.; 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)pyrimidinetrione Mixt. Contg. (9CI); Atrium; Atrium (pharmaceutical); 1,3-Bis[2-[(aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-Pyrimidinetrione Mixt. with 1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;

库存
7,034 克
纯度
98.5 %
CAS
60763-47-5

化合物标识与属性

CAS
60763-47-5
PubChem CID
114965
SMILES
CCCCOCC(CN1C(=O)C(C(=O)NC1=O)(CC)C2=CC=CC=C2)OC(=O)N.CCCCOCC(CN1C(=O)C(C(=O)N(C1=O)CC(COCCCC)OC(=O)N)(CC)C2=CC=CC=C2)OC(=O)N.CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
Canonical SMILES
CCC1(c2ccccc2)C(=O)NC(=O)NC1=O.CCCCOCC(CN1C(=O)N(CC(COCCCC)OC(N)=O)C(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O.CCCCOCC(CN1C(=O)NC(=O)C(CC)(c2ccccc2)C1=O)OC(N)=O

名称与同义词

  • Tetrabamate
  • Atrium (drug)
  • Atrium 300
  • AC1L3GAH
  • RefChem:1083544
  • AC1Q6KZ5
  • SCHEMBL1651427
  • KST-1A6654
  • KCA76347
  • AR-1A8847
  • CID114965
  • 60763-47-5
  • difebarbamate - febarbamate - phenobarbital
  • Difebarbamate mixture with febarbamate and phenobarbital
  • difebarbamate, febarbamate, phenobarbital drug combination
  • [2-butoxy-1-[[3-(3-butoxy-2-carbamoyloxy-propyl)-5-ethyl-2,4,6-trioxo-5-phenyl-hexahydropyrimidin-1-yl]methyl]ethyl] carbamate;[1-(butoxymethyl)-2-(5-ethyl-2,4,6-trioxo-5-phenyl-hexahydropyrimidin-1-yl)ethyl]carbamate; 5-ethyl-5-phenyl-hexahydropyrimidine-2,4,6-trione
  • [1-butoxy-3-[3-(3-butoxy-2-carbamoyloxypropyl)-5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] carbamate;[1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
  • 62533-89-5
  • [1-butoxy-3-[3-(3-butoxy-2-carbamoyloxypropyl)-5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl]propan-2-yl] carbamate; [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate; 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
  • 1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione Mixt. Contg.; 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)pyrimidinetrione Mixt. Contg. (9CI); Atrium; Atrium (pharmaceutical); 1,3-Bis[2-[(aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-Pyrimidinetrione Mixt. with 1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione;
  • 2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-bis(2-((aminocarbonyl)oxy)-3-butoxypropyl)-5-ethyl-5-phenyl-, mixt. with 1-(2-((aminocarbonyl)oxy)-3-butoxypropyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione